Home / Congress Presentations / PNH / European Society for Blood and Marrow Transplantation (EBMT) 2022
Landing
The European Society for Blood and Marrow Transplantation (EBMT) 2022
Hemoglobin, Lactate Dehydrogenase, and FACIT-Fatigue Normalization Rates in Patients Treated with Pegcetacoplan: Results from the PEGASUS and PRINCE Phase 3 Clinical Trials
Pegcetacoplan Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels at or above 10 Grams per Deciliter: A Post Hoc Analysis
Pegcetacoplan Treatment Meaningfully Improves Quality Of Life And Fatigue In Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From Two Phase 3 Clinical Trials
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.